Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
Clin Oncol (R Coll Radiol) ; 15(3): 136-8, 2003 May.
Artigo em Inglês | MEDLINE | ID: mdl-12801052

RESUMO

Metastases from cutaneous basal cell carcinomata are extremely rare phenomena. The majority of haematogenous metastases occur (in descending order) in the lung, skin and liver. The ratio of lymphogenic to haematogenic metastases is approximately 1 to 1. An exceedingly rare case of a metastasis to skeletal muscle is presented.


Assuntos
Carcinoma Basocelular/secundário , Neoplasias Musculares/secundário , Neoplasias Cutâneas/patologia , Dorso , Humanos , Imageamento por Ressonância Magnética , Masculino , Pessoa de Meia-Idade , Dor/etiologia
4.
Australas Radiol ; 43(2): 262-5, 1999 May.
Artigo em Inglês | MEDLINE | ID: mdl-10901915

RESUMO

Leiomyosarcoma of the rectum is an exceedingly rare malignancy and for this reason the literature fails to provide definitive management guidelines with regard to the place of adjuvant therapies. The role of radiotherapy (RT) is often downplayed on the basis of articles written at a time when state-of-the art RT equipment was unavailable. A case of leiomyosarcoma of the rectum is presented and the literature is reviewed. Because the rarity of this tumour type virtually precludes a prospective randomized trial of adjuvant therapies, the authors recommend (in otherwise fit patients) postoperative pelvic RT because its morbidity is minimal. Smaller tumours may benefit to a greater extent than those lesions that are large at presentation and thereby run a worse clinical course.


Assuntos
Leiomiossarcoma/radioterapia , Neoplasias Retais/radioterapia , Humanos , Leiomiossarcoma/cirurgia , Masculino , Pessoa de Meia-Idade , Radioterapia Adjuvante , Neoplasias Retais/cirurgia
5.
Australas Radiol ; 43(1): 58-68, 1999 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-10901872

RESUMO

From 1957 to 1992, 18 cases of primary mediastinal germ cell tumours were referred to the Peter MacCallum Cancer Institute (PMCI). Six were seminomas, six were mixed germ cell tumours, two were embryonal cell carcinomas, three were teratocarcinomas and one was labelled an 'anaplastic germ cell tumour'. Two of the 18 patients were female. For seminomas, surgical (and in one case chemotherapeutic) debulking, followed by radiotherapy produced the best results. Mediastinal doses ranged from 30 to 40 Gy. Local control was achieved in those patients receiving mediastinal radiotherapy. Four patients currently survive disease-free. The non-seminomatous germ cell tumours showed a significantly poorer survival, and only two of 12 patients remain alive in remission at 110 and 130 months after diagnosis. Survival has been updated as of November 1997. Attention is focused on the anterior position of the primary germ cell tumours in the mediastinum. A review of the literature up to and including 1997 is presented.


Assuntos
Neoplasias do Mediastino/patologia , Neoplasias Embrionárias de Células Germinativas/patologia , Adolescente , Adulto , Criança , Pré-Escolar , Terapia Combinada , Disgerminoma/mortalidade , Disgerminoma/patologia , Disgerminoma/terapia , Feminino , Humanos , Lactente , Masculino , Neoplasias do Mediastino/mortalidade , Neoplasias do Mediastino/terapia , Pessoa de Meia-Idade , Neoplasias Embrionárias de Células Germinativas/mortalidade , Neoplasias Embrionárias de Células Germinativas/terapia , Análise de Sobrevida , Teratoma/mortalidade , Teratoma/patologia , Teratoma/terapia , Resultado do Tratamento
6.
Lung Cancer ; 19(3): 167-77, 1998 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-9631364

RESUMO

A retrospective analysis was performed to determine whether coronal thoracic [18F]fluoro-2-deoxy-glucose positron emission tomography (FDG-PET) scans, if viewed at the time of radiotherapy (RT) planning, would have influenced the anterior-posterior (AP) RT volumes that were administered to a group of unoperated lung cancer patients. Viewing of PET and diagnostic images enabled a qualitative assessment of whether abnormal thoracic PET activity was present in areas regarded as normal by diagnostic imaging; this would, therefore, have influenced the RT volume if done prospectively. Additionally a method of graphical co-registration was devised to quantitate the adequacy of coverage of each patient's abnormal PET activity by his/her actual RT field. Of 15 patients analyzed, 26.7% (four patients) would have had their RT volume influenced by PET findings, highlighting the potential value of PET in treatment planning.


Assuntos
Fluordesoxiglucose F18 , Neoplasias Pulmonares/diagnóstico por imagem , Neoplasias Pulmonares/radioterapia , Planejamento da Radioterapia Assistida por Computador , Radioisótopos de Flúor , Humanos , Estudos Retrospectivos , Tomografia Computadorizada de Emissão
9.
Australas Radiol ; 38(4): 342-4, 1994 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-7993268

RESUMO

The new Radiation Oncology Department at the Heidelberg Repatriation Hospital in Melbourne, Australia commenced operation in June 1992. As part of quality control the Philips SL-15 linear accelerator was fitted with the Philips SRI-100 Real Time Portal Imaging Device (RTPID), the first such apparatus in Australia. One of its major advantages over older systems is its ability to provide a permanent hard copy of the image of the field treated. The computer image can be immediately manipulated and enhanced on the screen (with respect to such qualities as brightness and contrast) prior to the printing of the hard copy. This is a significant improvement over the more cumbersome older port films that required developing time, without any pre-assessment of the image quality. The utility of the Philips SRI-100 RTPID is demonstrated in the case of a patient irradiated soon after total hip replacement, as prophylaxis against heterotopic bone formation (HBF). The rapidity and quality of image production is a major advantage in these patients where post-operative pain may result in positional change between film exposure and image production. Extremely accurate shielding block position is essential to shield the prosthesis (and allow bone ingrowth for fixation) whilst avoiding inadvertent shielding of the areas at risk for HBF. A review of the literature is provided.


Assuntos
Articulação do Quadril , Prótese de Quadril/efeitos adversos , Ossificação Heterotópica/prevenção & controle , Aceleradores de Partículas , Radioterapia de Alta Energia/instrumentação , Adulto , Articulação do Quadril/efeitos da radiação , Humanos , Masculino , Ossificação Heterotópica/etiologia , Radioterapia de Alta Energia/métodos
10.
Int J Radiat Oncol Biol Phys ; 17(4): 835-41, 1989 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-2550400

RESUMO

From 1957 to 1988 eleven cases of primary mediastinal germ cell tumor were referred to the Peter MacCallum Cancer Institute (PMCI). Four were seminomas, three were mixed germ cell tumors, two were embryonal carcinomas and two were teratocarcinomas. Two of the eleven patients were female. For seminoma, surgical debulking and post-operative irradiation produced the best results. Mediastinal doses ranged from 30 to 37.5 Gy. Local control was achieved in all cases; two patients survive disease-free. The non-seminomatous germ cell tumors showed a significantly poorer survival with only one of seven patients remaining alive in remission at 15 months. One other case of non-seminomatous tumor remains alive but in relapse at 23 months. Attention is focused on the anterior position of primary germ cell tumors in the mediastinum. A review of the literature is presented.


Assuntos
Disgerminoma/patologia , Neoplasias do Mediastino/patologia , Neoplasias Embrionárias de Células Germinativas/patologia , Teratoma/patologia , Adulto , Terapia Combinada , Disgerminoma/mortalidade , Disgerminoma/terapia , Feminino , Humanos , Lactente , Masculino , Neoplasias do Mediastino/mortalidade , Neoplasias do Mediastino/terapia , Pessoa de Meia-Idade , Neoplasias Embrionárias de Células Germinativas/mortalidade , Neoplasias Embrionárias de Células Germinativas/terapia , Teratoma/mortalidade , Teratoma/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...